Cargando…
Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients
Study of the prognostic impact of multidrug resistance gene expression in the management of breast cancer in the context of adjuvant therapy. This study involved 171 patients treated by surgery, adjuvant chemotherapy±radiotherapy±hormonal therapy (mean follow-up: 55 months). We studied the expressio...
Autores principales: | Moureau-Zabotto, L, Ricci, S, Lefranc, J P, Coulet, F, Genestie, C, Antoine, M, Uzan, S, Lotz, J P, Touboul, E, Lacave, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361174/ https://www.ncbi.nlm.nih.gov/pubmed/16434992 http://dx.doi.org/10.1038/sj.bjc.6602958 |
Ejemplares similares
-
Comparative evaluation by semiquantitative reverse transcriptase polymerase chain reaction of MDR1, MRP and GSTp gene expression in breast carcinomas.
por: Lacave, R., et al.
Publicado: (1998) -
Mouse‐Human Chimeric Antibody MH171 against the Multidrug Transporter P‐Glycoprotein
por: Ariyoshi, Keiko, et al.
Publicado: (1992) -
At PS171 (ASTERIX)
Publicado: (1983) -
171th RB Meeting
Publicado: (2005) -
Memorandum: PS171 experiment
por: Klempt, E
Publicado: (1982)